Phathom Pharmaceuticals
PHAT
PHAT
117 hedge funds and large institutions have $504M invested in Phathom Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
17.7% more ownership
Funds ownership: 77.04% → 94.74% (+18%)
11% more capital invested
Capital invested by funds: $453M → $504M (+$51.7M)
6% more funds holding
Funds holding: 110 → 117 (+7)
Holders
117
Holding in Top 10
8
Calls
$415K
Puts
$77K
Top Buyers
| 1 | +$6.24M | |
| 2 | +$5M | |
| 3 | +$3.25M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.86M |
| 5 |
BlackRock
New York
|
+$2.2M |
Top Sellers
| 1 | -$4.58M | |
| 2 | -$4.47M | |
| 3 | -$2.53M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.41M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.29M |